Loading organizations...
Key people at Torrey Pines Investment.
Torrey Pines Investment is a life-science investment firm, focusing on early to development-stage therapeutic assets. It leads investment syndicates, targeting companies with clinical proof of concept achievable within three years. The firm supports portfolio companies with product and corporate development, leveraging expertise in drug discovery, clinical studies, manufacturing, and regulatory strategy.
Established in San Diego in 2012, Torrey Pines Investment was founded on the insight that strategic involvement enhances biotech and pharma investment. Ronald MBS Demuth is Founding President, Nikolay Savchuk, Ph.D., Managing Member, and Michael G. Palfreyman, Ph.D., DSc, leads due diligence, leveraging their combined industry backgrounds.
The firm partners with innovative biotech and pharmaceutical companies developing novel therapies. Its vision centers on capitalizing on unique opportunities where strategic input advances development and regulatory pathways. This is achieved by integrating expertise and resources from portfolio CRO companies, propelling life science innovations.
Key people at Torrey Pines Investment.
Torrey Pines Investment has 3 tracked investments across 3 companies. The latest tracked deal is $3.5M Seed in BIMINI Biotech in January 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 13, 2025 | BIMINI Biotech | $3.5M Seed | Torrey Pines Investment | — |
| Feb 26, 2016 | Chromis Therapeutics | $3.0M Seed | Torrey Pines Investment | — |
| Sep 10, 2014 | Avelas Biosciences | $550K Series B Extension | — | Avalon Ventures, WuXi AppTec |
